SNORA84

Across TCGA pan-cancer cohorts, SNORA84 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated SNORA84 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SNORA84 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNORA84 expression acts as an unfavorable survival marker, although some lineages such as READ and STAD show a favorable association.

ACC, READ, and DLBC are the cancer types where SNORA84 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	III,IV	0.390	0.821	<.001	63	view →
READ	OS	Median	II,III,IV	0.775	0.320	.002	45	view →
DLBC	OS	Median	III,IV	0.407	0.797	.013	35	view →
LGG	DFS	Tertile	All	0.725	0.866	<.001	28	view →
LIHC	OS	Tertile	II,III,IV	0.458	0.725	.007	27	view →
HNSC	OS	Tertile	II,III,IV	0.424	0.682	.003	26	view →
THCA	OS	Tertile	II,III,IV	0.890	0.971	.015	24	view →
STAD	OS	Quartile	IV	0.654	0.166	.017	15	view →
KIRP	OS	Tertile	III,IV	0.184	0.691	.021	12	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.846	.012	7	view →
SKCM	DFS	Tertile	IV	0.699	0.185	.025	3	view →
SARC	OS	Tertile	All	0.335	0.551	.024	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

SNORA84–ACC (OS)

Open the ACC breakdown →